Table 1 Correlation between circRPPH1 expression and clinicopathological features in 60 TNBC patients
Characteristics | Â | CircRPPH1 | P value | Â |
|---|---|---|---|---|
| Â | Low | High | Â | |
| Â | 30 | 30 | Â | |
Age |  ≥ 50 | 12 (20%) | 13 (21.7%) | 0.793 |
 < 50 | 18 (30%) | 17 (28.3%) |  | |
Menopausal | Postmenopausal | 11 (18.3%) | 12 (20%) | 0.791 |
Premenopausal | 19 (31.7%) | 18 (30%) | Â | |
Grage | II | 18 (30%) | 12 (20%) | 0.121 |
III | 12 (20%) | 18 (30%) | Â | |
T stage | T1 | 18 (30%) | 7 (11.7%) | 0.004** |
T2-3 | 12 (20%) | 23 (38.3%) | Â | |
N stage | N0 | 21 (35%) | 13 (21.7%) | 0.037* |
N1-3 | 9 (15%) | 17 (28.3%) | Â | |
TNM stage | I | 14 (23.3%) | 3 (5%) | 0.002** |
II/III | 16 (26.7%) | 27 (45%) | Â | |
Vascular invasion | No | 21 (35%) | 18 (30%) | 0.417 |
Yes | 9 (15%) | 12 (20%) | Â |